Use of recrystallized lactose as carrier for inhalation powder of interferon α2b

Pharmazie

Volumn 60, Issue 8, 2005, Pages 632-633

  Jiang, R G ^a   Pan, Weisan S ^a   Wang, C L ^b   Liu, H ^b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b TIANJIN INSTITUTE OF PHARMACEUTICAL RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; ALCOHOL; DRUG CARRIER; GLYCEROL; LACTOSE; RECOMBINANT ALPHA2B INTERFERON; WATER;

AEROSOL; ARTICLE; ATOMIC FORCE MICROSCOPY; CRYSTALLIZATION; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRY POWDER; ENERGY; FLOW RATE; GAS CHROMATOGRAPHY; PARTICLE SIZE; POWDER;

ANTIVIRAL AGENTS; DRUG CARRIERS; ELECTROCHEMISTRY; INTERFERON ALFA-2B; LACTOSE; MICROSCOPY, ATOMIC FORCE; PARTICLE SIZE; POWDERS;

EID: 23844484169     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Jiang RG, Wang CL, Liu H (2004) Methods and compositions for pulmonary delivery of Interferon α-2b. CN Patent 200410018796x.
2. Young PM, Cocconi D (2002) Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing". J Pharm Pharmacol 54: 1339-1344.
3. Zeng XM, Martin GP, Marriott C, Pritchard J (2000) The influence of crystallization conditions on the morphology of lactose intended for use as a carrier for dry powder aerosols. J Pharm Pharmcol 52: 633-643.
4. Zeng XM, Martin GP, Marriott C, Pritchard J (2001) Lactose as a carrier in dry powder formulations: the influence of surface characteristics on drug delivery. J Pharm Sci 90: 1424-1434.